kd-247
mAbexperimental
Clinical trial activity
1 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2007 (NCT00917813)
Timeline
2000s
- Jan 1, 2007
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Envelope polyprotein GP160INHIBITOR
ENV inhibitor
- Envelope glycoprotein gp160INHIBITOR
Q993A8 inhibitor
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL2109446 ↗
Also known as
- kd-247
- kd-247
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00917813 | Phase 1 | Sep 1, 2007 | The Chemo-Sero-Therapeutic Research Institute |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| The Chemo-Sero-Therapeutic Research Institute | Academic/Hospital | 1 | 1 | 1 | 2007 |
1 organizations
Page 1 / 1